Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70

Oncology Reports

Volumn 21, Issue 3, 2009, Pages 737-746

  Koide, Taihei ^a   Iinuma, Hisae ^a   Fukushima, Ryoji ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytotoxic T lymphocyte; Fusion cell; Gastric cancer; Heat shock protein 70

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HLA DR ANTIGEN; MESSENGER RNA; PICIBANIL; TUMOR ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CD8+ T LYMPHOCYTE; CELL FUSION; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FREEZE THAWING; GENE EXPRESSION REGULATION; HEAT STRESS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFERON PRODUCTION; LEUKEMIA CELL LINE; LYMPHOCYTOPOIESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR CELL; UPREGULATION;

ANTIGENS, NEOPLASM; CANCER VACCINES; CELL FUSION; CELL LINE, TUMOR; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYBRID CELLS; LYMPHOCYTE ACTIVATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 64849087044     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000279     Document Type: Article

References (32)

1. Inaba K, Metlay JP, Crowley MT, Witmer-Pack M and Steinman RM: Dendritic cells as antigen presenting cells in vivo. Int Rev Immunol 6: 197-206, 1990.
2. Apostolopolus V, Weiner DB and Gong J: Cancer vaccines: methods for inducing immunity. Expert Rev Vaccines 8: 861-862, 2008.
3. Tacken PJ, De Vries IJ, Torensma R and Figdor CG: Dectritic immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 7: 790-802, 2007.
4. Yasuda T, Kamigaki T, Nakamura T, et al: Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: A comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells. Oncol Rep 16: 1317-1324, 2006.
5. Shimizu K, Kuriyama H, Kjaergaard J, Lee W, Tanaka H and Shu S: Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy. J Immunother 27: 265-272, 2004.
6. Ogawa F, Iinuma H and Okinaga K: Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells. Scand J Immunol 59: 432-439, 2004.
7. Iinuma H, Okinaga K, Fukushima R, et al: Superior protective and therapeutic effects of IL-12 and IL-18 gene-transduced dendritic neuroblastoma fusion cells on liver metastasis of murine neuroblastoma. J Immunol 176: 3461-3469, 2006.
8. Takeda A, Homma S, Okamoto T, Kufe D and Ohno T: Immature dendritic cell/ tumor cell fusions induce potent antitumour immunity. Eur J Clin Invest 33: 897-904, 2003.
9. Tanaka Y, Koido S, Ohana M, Liu C and Gong J: Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells. J Immunol 174: 1274-1280, 2005.
10. Iinuma H and Okinaga K: Cancer immunotherapy based on DC-tumor fusion vaccine. Biotherapy 21: 48-55, 2007.
11. Krause SW, Neumann C, Soruri A, et al: The treatment of patients with disseminated malignnant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells. J Immunother 25: 421-428, 2002.
12. Marten A, Renoth S, Heinicke T, et al: Allogeneic dendritic cells fused with tumor cells:preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma. Hum Gene Ther 14: 483-494, 2003.
13. Trefzer U, Herberth G, Wohlan K, et al: Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients. Int J Cancer 110: 730-740, 2004.
14. Kikuchi T, Akasaki Y, Abe T, et al: Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12. J Immunother 27: 452-459, 2004.
15. Haenssle HA, Krause SW, Emmer S, et al: Hybrid cell vaccination in metstatic melanoma: clinical and immunologic results of a phase I/II study. J Immunother 27: 147-155, 2004.
16. Homma S, Kikuchi T, Ishiji N, et al: Cancer immunotherapy by fusions of dendritic and tumor cells and rh-IL-12. Eur J Clin Invest 35: 279-286, 2005.
17. Avigan DE, Vasir B, George DJ, et al: Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. J Immunother 30: 749-761, 2007.
18. Enomoto Y, Bharti A, Khaleque AA, et al: Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. J Immunol 177: 5946-5955, 2006.
19. Kurotaki T, Tamura Y, Ueda G, et al: Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J Immunol 179: 1803-1813, 2007.
20. Udono H and Srivastava PK: Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178: 1391-1396, 1993.
21. Castelli C, Ciupitu AM, Rini F, et al: Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res 61: 222-227, 2001.
22. Bendz H, Ruhland SC, Pandya MJ, et al: Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling. J Biol Chem 282: 31688-31702, 2007.
23. Koido S, Hara E, Homma S, et al: Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells. J Immunol 179: 4874-4883, 2007.
24. Ogihara T, Iinuma H and Okinaga K: Usefulness of immunomodulators for maturation of dendritic cells. Int J Oncol 25: 453-459, 2004.
25. Jin G, Kubo H, Kashiba M, et al: Saposin B is a Human coenzyme Q10-binding/transfer protein. J Clin Biochem Nutr 42: 167-174, 2008.
26. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD and Wagner H: HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway. J Biol Chem 277: 15107-15112, 2002.
27. Delneste Y, Magistrelli G, Gauchat J, et al: Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353-362, 2002.
28. Binder RJ, Vatner R and Srivastava P: The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64: 442-451, 2004.
29. Thériault JR, Mambula SS, Sawamura T, Stevenson MA and Calderwood SK: Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. FEBS Lett 579: 1951-1960, 2005.
30. Bukau B and Horwich AL: The Hsp70 and Hsp60 chaperone machines. Cell 92: 351-366, 1998.
31. Tang D, Khaleque MA, Jones EL, et al: Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones 10: 46-58, 2005.
32. Fourie AM, Peterson PA and Yang Y: Characterization and regulation of the major histocompatibility complex-encoded proteins Hsp70-Hom and Hsp70-1/2. Cell Stress Chaperones 6: 282-295, 2001.